Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-209.56M
↓ 96% vs avg
Percentile
P9
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-106.77M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-209.56M | -0.5% |
| 2024 | $-208.57M | +13.9% |
| 2023 | $-242.30M | -185.8% |
| 2022 | $-84.78M | -29.1% |
| 2021 | $-65.65M | +19.4% |
| 2020 | $-81.48M | -1.4% |
| 2019 | $-80.33M | -76.7% |
| 2018 | $-45.46M | -64.3% |
| 2017 | $-27.68M | -26.3% |
| 2016 | $-21.91M | - |